{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:11:23Z","timestamp":1648779083471},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1990,1,1]],"date-time":"1990-01-01T00:00:00Z","timestamp":631152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[1990]]},"DOI":"10.1007\/bf00858636","type":"journal-article","created":{"date-parts":[[2005,1,8]],"date-time":"2005-01-08T01:48:53Z","timestamp":1105148933000},"page":"614-617","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of calcium carbonate and low-dose vitamin D\/1,25(OH)2D3 in reducing the risk of developing renal osteodystrophy in children on continuous ambulatory peritoneal dialysis"],"prefix":"10.1007","volume":"4","author":[{"given":"Harald","family":"J\ufffdppner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Friedrich","family":"Hoyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Latta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lothar","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gisela","family":"Offner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Brodehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"498","volume":"2","author":"A Fournier","year":"1987","unstructured":"Fournier A, Moriniere P, Boudaillez B, Renaud H, Marie A, Westeel PF, Hocine C, Belbrik S (1987) 1,25(OH)2 Vitamin D3 deficiency and renal osteodystrophy: should its well-accepted pathogenetic role in secondary hyperparathyroidism lead to its systematic preventive therapeutic use? Nephrol Dial Transplant 2: 498?503","journal-title":"Nephrol Dial Transplant"},{"key":"CR2","first-page":"309","volume-title":"Bone and mineral research, vol 5","author":"E Ritz","year":"1987","unstructured":"Ritz E, Dr\u00fceke T, Merke J, Lukas PA (1987) Genesis of bone disease in uremia. In: Peck WA (ed) Bone and mineral research, vol 5. Elsevier, Amsterdam, pp 309"},{"key":"CR3","first-page":"1032","volume-title":"Endocrinology","author":"IB Salusky","year":"1989","unstructured":"Salusky IB, Coburn JW (1989) The renal osteodystrophies. In: DeGroot LJ (ed) Endocrinology. Sauders, Philadelphia, pp 1032"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ki.1988.58","volume":"33","author":"RL Prince","year":"1988","unstructured":"Prince RL, Hutchison BG, Kent JC, Kent GN, Retallack RW (1988) Calcitriol deficiency with retained synthetic reserve in chronic renal failure. Kidney Int 33: 722?728","journal-title":"Kidney Int"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1210\/jcem-61-4-601","volume":"61","author":"F Llach","year":"1985","unstructured":"Llach F, Massry SG (1985) On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency. J Clin Endocrinol Metab 61: 601?606","journal-title":"J Clin Endocrinol Metab"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2265.1981.tb00191.x","volume":"14","author":"JR Juttmann","year":"1981","unstructured":"Juttmann JR, Buurman CJ, De Kam E, Visser TJ, Birkenh\u00e4ger JC (1981) Serum concentrations of vitamin D in patients with chronic renal failure (CRF). Consequences for the treatment with 1-alpha-hydroxy-derivatives. Clin Endocrinol 14: 225?236","journal-title":"Clin Endocrinol"},{"key":"CR7","first-page":"1209","volume-title":"Vitamin D: basic research and clinical application","author":"D Slatopolsky","year":"1979","unstructured":"Slatopolsky D, Gray R, Adam ND, Lewis J, Hruska K, Martin K, Klahr S, DeLuca H, Lemann J (1979) The pathogenesis of secondary hyperparathyroidism in early renal failure. In: Normann A, Schaeffer K, Herrath D von (eds) Vitamin D: basic research and clinical application. de Gruyter, New York, pp 1209"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ki.1983.131","volume":"24","author":"AK Cheung","year":"1983","unstructured":"Cheung AK, Manolagas SC, Catherwood BD, Mosely CA, Mitas JA, Blantz RC, Deftos LJ (1983) Determinants of serum 1,25(OH)2D levels in renal disease. Kidney Int 24: 104?109","journal-title":"Kidney Int"},{"key":"CR9","first-page":"848","volume-title":"Endocrinology","author":"M Rosenblatt","year":"1989","unstructured":"Rosenblatt M, Kronenberg HM, Potts JT Jr (1989) Parathyroid hormone: physiology, chemistry, biosynthesis, secretion, metabolism and mode of action. In: DeGroot LJ (ed) Endocrinology, Saunders, Philadelphia, pp 848"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/jbmr.5650030502","volume":"3","author":"SJ Marx","year":"1988","unstructured":"Marx SJ, Barsony J (1988) Tissue-selective 1,25-dihydroxyvitamin D3 resistance: novel applications of calciferols. J Bone Miner Res 3: 481?487","journal-title":"J Bone Miner Res"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1210\/jcem-53-4-823","volume":"53","author":"S Madson","year":"1981","unstructured":"Madson S, Olgaard K, Ladgefoged J (1981) Suppressive effect of 1,25(OH)2 vitamin D 3 on circulating parathyroid hormone in acute renal failure. J Clin Endocrinol Metab 53: 823?827","journal-title":"J Clin Endocrinol Metab"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI111639","volume":"74","author":"E Slatopolsky","year":"1984","unstructured":"Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin K (1984) Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25 dihydroxycholecalciferol in uremic patients. J Clin Invest 74: 2136?2143","journal-title":"J Clin Invest"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJM198706183162504","volume":"316","author":"A Korkor","year":"1987","unstructured":"Korkor A (1987) Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure. N Engl J Med 316: 1573?1577","journal-title":"N Engl J Med"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1210\/jcem-54-1-172","volume":"54","author":"EM Brown","year":"1982","unstructured":"Brown EM, Wilkson RE, Eastman RC, Pallotta J, Marynick SP (1982) Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure. J Clin Endocrinol Metab 54: 172?179","journal-title":"J Clin Endocrinol Metab"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/BF01116888","volume":"4","author":"R Larsson","year":"1984","unstructured":"Larsson R, Wallfelt C, Abrahamsson H, Gylfe E, Ljunghall S, Rastad J, Rosman P, Wide L, \u00c5kerstr\u00f6m G (1984) Defective regulation of the cytosolic calcium activity in parathyroid cells from patients with hyperparathyroidism. Biosci Rep 4: 909?915","journal-title":"Biosci Rep"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1172\/JCI112666","volume":"78","author":"S Lopez-Hilker","year":"1986","unstructured":"Lopez-Hilker S, Galceran T, Chan YL, Rapp N, Martin KJ, Slatoposky E (1986) Hypocalcemia may not be essential for the development of secondary hyperparathyroidism in chronic renal failure. J Clin Invest 78: 1097?1102","journal-title":"J Clin Invest"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1073\/pnas.84.9.2990","volume":"84","author":"C Juhlin","year":"1987","unstructured":"Juhlin C, Holmdahl R, Johansson H, Rastad J, \u00c5kerstr\u00f6m G, Klareskog L (1987) Monoclonal antibodies with exclusive reactivity against parathyroid cells and tubule cells of the kidney. Proc Natl Acad Sci USA 84: 2990?2994","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1210\/endo-122-6-2999","volume":"122","author":"C Juhlin","year":"1988","unstructured":"Juhlin C, Klareskog L, Nygren P, Ljunghall S, Gylfe E, Rastad J, \u00c5kerstr\u00f6m G (1988) Hyperparathyroidism is associated with reduced expression of a parathyroid calcium receptor mechanism defined by monoclonal antiparathyroid antibodies. Endocrinology 122: 2999?3001","journal-title":"Endocrinology"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ki.1986.252","volume":"30","author":"JA Ramirez","year":"1986","unstructured":"Ramirez JA, Emmet H, White MG, Fathi N, Sauta Ana CA, Morawski SG, Fordtrau JS (1986) The absorption of dietary phosphorus and calcium in hemodialysis patients. Kidney Int 30: 753?759","journal-title":"Kidney Int"},{"issue":"Suppl 15","key":"CR20","first-page":"S101","volume":"24","author":"IB Salusky","year":"1983","unstructured":"Salusky IB, Kopple JD, Fine RN (1983) Continuous ambulatory peritoneal dialysis in pediatric patients: a 20-month experience. Kidney Int 24 [Suppl 15]: S101-S105","journal-title":"Kidney Int"},{"key":"CR21","first-page":"163","volume":"17","author":"J Brodehl","year":"1982","unstructured":"Brodehl J, Gellissen K, Weber HP (1982) Postnatal development of tubular phosphate reabsorption. Clin Nephrol 17: 163?171","journal-title":"Clin Nephrol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF03349458","volume":"4","author":"M Atkinson","year":"1981","unstructured":"Atkinson M, Niepel B, J\u00fcppner H, Casaretto M, Zahn H, Hehrmann R, Hesch RD (1981) Homologous radioimmunoassay for human mid-regional parathyroid hormone. J Endocrinol Invest 4: 363?366","journal-title":"J Endocrinol Invest"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF01711939","volume":"64","author":"H J\u00fcppner","year":"1986","unstructured":"J\u00fcppner H, Atkinson M, Ringe B, Krohn HP, Hesch RD (1986) Mitt-C-regionales Parathormon in der klinischen Routine: Diagnostische Wertigkeit beim extrarenalen (prim\u00e4ren) und renalen (sekund\u00e4ren) Hyperparathyreodismus. Klin Wochenschr 64: 281?286","journal-title":"Klin Wochenschr"},{"key":"CR24","first-page":"1","volume-title":"Atlas of skeletal development of the hand and wrist","author":"WW Greulich","year":"1957","unstructured":"Greulich WW, Pyle SI (1957) Atlas of skeletal development of the hand and wrist, 2nd edn. Stanford University Press, Stanford, p 1","edition":"2nd edn."},{"key":"CR25","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/adc.41.219.454","volume":"41","author":"JM Tanner","year":"1966","unstructured":"Tanner JM, Whitehouse RH, Takaishi M (1966) Standards from birth to maturity for height, weight, height velocity and weight velocity: British children. Arch Dis Child 41: 454?468","journal-title":"Arch Dis Child"},{"issue":"Suppl 27","key":"CR26","first-page":"S133","volume":"36","author":"P Moriniere","year":"1989","unstructured":"Moriniere P, Hocine C, Boudailliez B, Belbrik S, Renaud H, Westeel PF, Cohen Solal MC, Fournier A (1989) Long-term efficacy and safety of oral calcium as compared to AI(OH)3 as phosphate binders. Kidney Int 36 [Suppl 27]: S133-S135","journal-title":"Kidney Int"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/bmj.291.6496.623","volume":"291","author":"RHK Mak","year":"1985","unstructured":"Mak RHK, Turner C, Thompson T, Powell H, Haycock GB, Chantler C (1985) Suppression of secondary hyperparathyroidism in children with chronic renal failure by high dose phosphate binders: calcium carbonate versus aluminium hydroxide. Br Med J 291: 623?627","journal-title":"Br Med J"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/jama.1979.03290380018018","volume":"241","author":"JCM Chan","year":"1979","unstructured":"Chan JCM, DeLuca HF (1979) Calcium and parathyroid disorders in children: chronic renal failure and treatment with calcitriol. JAMA 241: 1242?1244","journal-title":"JAMA"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000403273","volume":"18","author":"RW Chesney","year":"1980","unstructured":"Chesney RW, Hamstra A, Jax DK, Mazess RB, DeLuca HF (1980) Influence of long-term oral 1,25 dihydroxy vitamin D in childhood renal osteodystrophy. Contrib Nephrol 18: 55?71","journal-title":"Contrib Nephrol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/ki.1987.176","volume":"32","author":"IB Salusky","year":"1987","unstructured":"Salusky IB, Fine RN, Kangarloo H, Gold R, Paunier L, Goodman WG, Brill JE, Gilli G, Slatopolsky E, Coburn JW (1987) ?Highdose? calcitriol for control of renal osteodystrophy in children on CAPD. Kidney Int 32: 89?95","journal-title":"Kidney Int"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/clinchem\/33.8.1364","volume":"33","author":"SR Nussbaum","year":"1987","unstructured":"Nussbaum SR, Zahradnik RJ, Lavigne JR, Brennan GL, Nozawa-Ung K, Kim LY, Keutmann HT, Wang C, Potts JT Jr, Segre GV (1987) Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 33: 1364?1367","journal-title":"Clin Chem"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1210\/jcem-63-5-1163","volume":"63","author":"DL Andress","year":"1986","unstructured":"Andress DL, Endress DB, Maloney NA, Kopp JB, Coburn JW, Sherrard DJ (1986) Comparison of parathyroid hormone assays with bone histomorphometry in renal osteodystrophy. J Clin Endocrinol Metab 63: 1163?1169","journal-title":"J Clin Endocrinol Metab"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1172\/JCI112483","volume":"77","author":"S Balsan","year":"1986","unstructured":"Balsan S, Garabedian N, Larchet M, Gorski AM, Cournot G, Tau C, Bordeau A, Silve C, Ricour C (1986) Long term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25 dihydroxy vitamin D. J Clin Invest 77: 1661?1667","journal-title":"J Clin Invest"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/276517a0","volume":"276","author":"A Ornoy","year":"1978","unstructured":"Ornoy A, Goodwin D, Noff D, Edelstein S (1978) 24,25-dihydroxyvitamin D is a metabolite of vitamin D essential for bone formation. Nature 276: 517?519","journal-title":"Nature"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/jbmr.5650020203","volume":"2","author":"C Lidor","year":"1987","unstructured":"Lidor C, Atkin I, Ornoy A, Dekel S, Edelstein S (1987) Healing of rachitic lesions in chicks by 24 R, 25-dihydroxycholecalciferol administered locally into bone. J Bone Miner Res 2: 91?98","journal-title":"J Bone Miner Res"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/ki.1984.220","volume":"26","author":"K Olgaard","year":"1984","unstructured":"Olgaard K, Finco D, Schwartz J, Arbelaez M, Teitelbaum S, Avioli L, Klahr S, Slatopolsky E (1984) Effect of 24,25(OH)2D3 on PTH levels and bone histology in dogs with chronic uremia. Kidney Int 26: 791?797","journal-title":"Kidney Int"},{"key":"CR37","first-page":"123","volume":"31","author":"R Demontis","year":"1989","unstructured":"Demontis R, Reissi D, Noel C, Boudailliez B, Westeel PF, Leflon P, Brasseur J, Coevoet B, Fournier A (1989) Indirect clinical evidence that 1-alpha OH vitamin D3 increases the intestinal absorption of aluminum. Clin Nephrol 31: 123?127","journal-title":"Clin Nephrol"},{"key":"CR38","first-page":"292","volume":"24","author":"R Diemen-Steenvoorde van","year":"1985","unstructured":"Diemen-Steenvoorde R van, Donckerwolcke RA, Bosch R, Visser WJ, Raymakers JA, Duursma SA (1985) Treatment of renal osteodystrophy in children with dihydrotachysterol and 24,25-dihydroxyvitamin D3. Clin Nephrol 24: 292?299","journal-title":"Clin Nephrol"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/cs0710539","volume":"71","author":"J Main","year":"1986","unstructured":"Main J, Velasco N, Heves SD, Whiting P, Fraser RA, Catto GRD (1986) The effect of dihydroxylated metabolites of vitamin D and dietary phosphate restriction on bone disease in uraemic rats. Clin Sci 71: 539?543","journal-title":"Clin Sci"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1210\/endo-124-1-511","volume":"124","author":"H Yamato","year":"1989","unstructured":"Yamato H, Matsumoto T, Fukumoto S, Ikeda K, Ishizuka S, Ogata E (1989) Effect of 24,25-dihydroxyvitamin D3 on 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] metabolism in vitamin D-deficient rats infused with 1,25-(OH)2D3. Endocrinology 124: 511?517","journal-title":"Endocrinology"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1210\/endo-124-5-2645","volume":"124","author":"J Abe","year":"1989","unstructured":"Abe J, Takita Y, Nakano T, Miyaura C, Suda T, Nishii Y (1989) A synthetic analogue of vitamin D3 is a potent modulator of in vivo immunoregulating activity without inducing hypercalcemia in mice. Endocrinology 124: 2645?2647","journal-title":"Endocrinology"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1172\/JCI114229","volume":"84","author":"AJ Brown","year":"1989","unstructured":"Brown AJ, Ritter CR, Finch JL, Morrissey J, Martin KJ, Murayama E, Nishi Y, Slatopolsky E (1989) The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion. J Clin Invest 84: 728?732","journal-title":"J Clin Invest"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00858636.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00858636\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00858636","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T07:40:12Z","timestamp":1586072412000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00858636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1990]]}},"alternative-id":["BF00858636"],"URL":"https:\/\/doi.org\/10.1007\/bf00858636","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990]]}}}